SARS-CoV-2 an infection, vaccination, and antibody reaction trajectories in adults: a cohort find out about in Catalonia | BMC Drugs


  • Ward H, Whitaker M, Flower B, Tang SN, Atchison C, Darzi A, et al. Inhabitants antibody responses following COVID-19 vaccination in 212,102 people. Nat Commun. 2022;13:907.

    CAS 
    Article 

    Google Student 

  • Moncunill G, Aguilar R, Ribes M, Ortega N, Rubio R, Salmerón G, et al. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of uncovered and naïve healthcare employees. EBioMedicine. 2022;75:103805.

    CAS 
    Article 

    Google Student 

  • Wei J, Pouwels KB, Stoesser N, Matthews PC, Diamond I, Studley R, et al. Antibody responses and correlates of coverage within the common inhabitants after two doses of the ChAdOx1 or BNT162b2 vaccines. Nat Med 2022. https://doi.org/10.1038/s41591-022-01721-6.

  • Dashdorj NJ, Wirz OF, Röltgen Okay, Haraguchi E, Buzzanco AS, Sibai M, et al. Direct comparability of antibody responses to 4 SARS-CoV-2 vaccines in Mongolia. Mobile Host Microbe. 2021;29:1738–1743.e4.

    CAS 
    Article 

    Google Student 

  • Ruggiero A, Piubelli C, Calciano L, Accordini S, Valenti MT, Carbonare LD, et al. SARS-CoV-2 vaccination elicits unconventional IgM particular responses in naïve and in the past COVID-19-infected people. EBioMedicine. 2022;77:103888.

    CAS 
    Article 

    Google Student 

  • Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y, et al. Systemic and mucosal IgA responses are variably precipitated in keeping with SARS-CoV-2 mRNA vaccination and are related to coverage in opposition to next an infection. Mucosal Immunol. 2022. https://doi.org/10.1038/s41385-022-00511-0.

  • Dobaño C, Jiménez A, Rubio R, Alonso S, Ramírez-Morros A, Vidal M, et al. Spike-based COVID-19 immunization will increase antibodies to nucleocapsid antigen. Transl Res. 2022;240:26–32.

    Article 

    Google Student 

  • Milne G, Hames T, Scotton C, Gent N, Johnsen A, Anderson RM, et al. Does an infection with or vaccination in opposition to SARS-CoV-2 result in lasting immunity? Lancet Respir Med. 2021;9:1450–66.

    CAS 
    Article 

    Google Student 

  • Peng Q, Zhou R, Wang Y, Zhao M, Liu N, Li S, et al. Waning immune responses in opposition to SARS-CoV-2 variants of outrage amongst vaccinees in Hong Kong. eBioMedicine. 2022;77:103904.

    CAS 
    Article 

    Google Student 

  • Bajema KL, Dahl RM, Prill MM, Meites E, Rodriguez-Barradas MC, Marconi VC, et al. Effectiveness of COVID-19 mRNA vaccines in opposition to COVID-19-associated hospitalization – 5 veterans affairs clinical facilities, United States, February 1-August 6, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1294–9.

    CAS 
    Article 

    Google Student 

  • Karachaliou M, Moncunill G, Espinosa A, Castaño-Vinyals G, Jiménez A, Vidal M, et al. An infection precipitated SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a common inhabitants cohort find out about in Catalonia Spain. Sci Rep. 2021;11:21571.

    CAS 
    Article 

    Google Student 

  • Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, et al. Speedy decay of anti-SARS-CoV-2 antibodies in individuals with gentle Covid-19. N Engl J Med. 2020;383:1085–7.

    Article 

    Google Student 

  • Zimmermann P, Curtis N. Elements that affect the immune reaction to vaccination. Clin Microbiol Rev. 2019;32:e00084–18.

    CAS 
    Article 

    Google Student 

  • Obón-Santacana M, Vilardell M, Carreras A, Duran X, Velasco J, Galván-Femenía I, et al. GCAT|Genomes for lifestyles: a potential cohort find out about of the genomes of Catalonia. BMJ Open. 2018;8:e018324.

    Article 

    Google Student 

  • Ortega N, Ribes M, Vidal M, Rubio R, Aguilar R, Williams S, et al. Seven-month kinetics of SARS-CoV-2 antibodies and position of pre-existing antibodies to human coronaviruses. Nat Commun. 2021;12:4740.

    CAS 
    Article 

    Google Student 

  • Dobaño C, Santano R, Jiménez A, Vidal M, Chi J, Rodrigo Melero N, et al. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: application and barriers in seroprevalence and immunity research. Transl Res J Lab Clin Med. 2021. https://doi.org/10.1016/j.trsl.2021.02.006.

  • ECDC. Variants of passion and fear within the EU/EEA.

  • Dobaño C, Vidal M, Santano R, Jiménez A, Chi J, Barrios D, et al. Extremely delicate and particular multiplex antibody assays to quantify immunoglobulins M, A, and G in opposition to SARS-CoV-2 antigens. J Clin Microbiol. 2021;59.

  • Catalan Ministry of Well being. Catalan Ministry of Well being Catalan epidemiological surveillance machine.

  • Gerussi V, Peghin M, Palese A, Bressan V, Visintini E, Bontempo G, et al. Vaccine hesitancy amongst Italian sufferers recovered from COVID-19 an infection in opposition to influenza and Sars-Cov-2 vaccination. Vaccines. 2021;9:172.

    CAS 
    Article 

    Google Student 

  • Nguyen LH, Joshi AD, Drew DA, Merino J, Ma W, Lo C-H, et al. Self-reported COVID-19 vaccine hesitancy and uptake amongst members from other racial and ethnic teams in america and United Kingdom. Nat Commun. 2022;13:636.

    CAS 
    Article 

    Google Student 

  • Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, et al. Immunity to SARS-CoV-2 as much as 15 months after an infection. iScience. 2022;25:103743.

    CAS 
    Article 

    Google Student 

  • Dobaño C, Ramírez-Morros A, Alonso S, Vidal-Alaball J, Ruiz-Olalla G, Vidal M, et al. Patience and baseline determinants of seropositivity and reinfection charges in well being care employees as much as 12.5 months after COVID-19. BMC Med. 2021;19:155.

    Article 

    Google Student 

  • Faro-Viana J, Bergman M-L, Gonçalves LA, Duarte N, Coutinho TP, Borges PC, et al. Inhabitants homogeneity for the antibody reaction to COVID-19 BNT162b2/Comirnaty vaccine is best reached after the second one dose throughout all grownup age levels. Nat Commun. 2022;13:140.

    CAS 
    Article 

    Google Student 

  • Koerber N, Priller A, Yazici S, Bauer T, Cheng C-C, Mijočević H, et al. Dynamics of spike-and nucleocapsid particular immunity right through long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nat Commun. 2022;13:153.

    CAS 
    Article 

    Google Student 

  • Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, et al. Affiliation between vaccination standing and reported occurrence of post-acute COVID-19 signs in Israel: a cross-sectional find out about of sufferers examined between March 2020 and November 2021. preprint. Epidemiology; 2022.

  • Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Chance elements for lengthy COVID: analyses of 10 longitudinal research and digital well being information in the United Kingdom. preprint. Epidemiology. 2021.

  • Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Chance elements and illness profile of post-vaccination SARS-CoV-2 an infection in UK customers of the COVID Symptom Learn about app: a potential, community-based, nested, case-control find out about. Lancet Infect Dis. 2022;22:43–55.

    CAS 
    Article 

    Google Student 

  • Bates TA, McBride SK, Leier HC, Guzman G, Lyski ZL, Schoen D, et al. Vaccination ahead of or after SARS-CoV-2 an infection ends up in powerful humoral reaction and antibodies that successfully neutralize variants. Sci Immunol. 2022;7:eabn8014.

    CAS 
    Article 

    Google Student 

  • Tsang JS, Dobaño C, VanDamme P, Moncunill G, Marchant A, Othman RB, et al. Making improvements to vaccine-induced immunity: can baseline expect end result? Traits Immunol. 2020;41:457–65.

    CAS 
    Article 

    Google Student 

  • Rotshild V, Hirsh-Raccah B, Miskin I, Muszkat M, Matok I. Evaluating the scientific efficacy of COVID-19 vaccines: a scientific evaluation and community meta-analysis. Sci Rep. 2021;11:22777.

    CAS 
    Article 

    Google Student 

  • Lafon E, Jäger M, Bauer A, Reindl M, Bellmann-Weiler R, Wilflingseder D, et al. Comparative analyses of IgG/IgA neutralizing results precipitated by means of 3 COVID-19 vaccines in opposition to variants of outrage. J Allergic reaction Clin Immunol. 2022;149:1242–1252.e12.

    CAS 
    Article 

    Google Student 

  • Fraussen J. IgM responses following SARS-CoV-2 vaccination: insights into protecting and pre-existing immunity. eBioMedicine. 2022;77:103922.

    CAS 
    Article 

    Google Student 

  • Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, et al. IgA dominates the early neutralizing antibody reaction to SARS-CoV-2. Sci Transl Med. 2021;13:eabd2223.

    CAS 
    Article 

    Google Student 

  • Munro APS, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, et al. Protection and immunogenicity of 7 COVID-19 vaccines as a 3rd dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the United Kingdom (COV-BOOST): a blinded, multicentre, randomised, managed, segment 2 trial. Lancet. 2021;398:2258–76.

    CAS 
    Article 

    Google Student 

  • Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, et al. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the overall inhabitants of the UK. Nat Microbiol. 2021;6:1140–9.

    CAS 
    Article 

    Google Student 

  • Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, et al. Age-related immune reaction heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021;596:417–22.

    CAS 
    Article 

    Google Student 

  • Notarte KI, Ver AT, Velasco JV, Pastrana A, Catahay JA, Salvagno GL, et al. Results of age, intercourse, serostatus, and underlying comorbidities on humoral reaction post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a scientific evaluation. Crit Rev Clin Lab Sci. 2022;1–18.

  • Ferrara P, Gianfredi V, Tomaselli V, Polosa R. The impact of smoking on humoral reaction to COVID-19 vaccines: a scientific evaluation of epidemiological research. Vaccines. 2022;10:303.

    CAS 
    Article 

    Google Student 

  • Mazereel V, Van Assche Okay, Detraux J, De Hert M. COVID-19 vaccination for other people with critical psychological sickness: why, what, and the way? Lancet Psychiatry. 2021;8:444–50.

    Article 

    Google Student 

  • Naruse H, Ito H, Izawa H, Sarai M, Ishii J, Sakaguchi E, et al. Immunogenicity of BNT162b2 mRNA COVID-19 vaccine in sufferers with heart problems. J Clin Med. 2021;10:5498.

    CAS 
    Article 

    Google Student 

  • Lee SW, Moon J-Y, Lee S-Okay, Lee H, Moon S, Chung SJ, et al. Anti-SARS-CoV-2 Spike protein RBD antibody ranges after receiving a 2d dose of ChAdOx1 nCov-19 (AZD1222) vaccine in healthcare employees: loss of affiliation with age, intercourse, weight problems, and antagonistic reactions. Entrance Immunol. 2021;12:779212.

    CAS 
    Article 

    Google Student 


  • Verepass helps sort through the science of COVID-19, process it, and offer an easy pathway to understanding your COVID-19 health, which will get you back to doing what you enjoy.